Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Trading Statement

11 Jan 2013 07:00

RNS Number : 3136V
Gleeson(M J)Group PLC
11 January 2013
 



 

11 January 2013

 

MJ GLEESON GROUP PLC

TRADING UPDATE

 

MJ Gleeson Group plc (GLE.L) is today issuing the following Trading Update ahead of its Half Year Results to 31 December 2012, which will be released on Thursday 28 February 2013.

 

Gleeson Homes

 

Gleeson Homes sold 164 private development homes during the period, an increase of 53% compared with the previous year's total of 107. With the inclusion of units sold to Housing Associations, the total for the period is 165 homes, compared to 130 in the comparable period.

 

Total sales, comprising reserved, contracted and completed homes, rose by 65% to £33.2m.

 

The Government's FirstBuy scheme, which provides support to first time buyers by way of a 20% equity loan, has been very popular with our customers. We have recently secured an additional allocation of £2.0m of FirstBuy funding, which will provide assistance to about 170 first time buyers.

 

During the period Gleeson Homes has continued to increase its landbank of plots with the addition of 331 plots. The landbank of plots at 31 December comprises 2,099 plots owned with a further 1,530 plots conditionally purchased, which, if acquired, will increase the landbank to in excess of 3,600 plots.

 

Gleeson Strategic Land

 

Demand for green field residential land in the South of England from the major housebuilders remains strong. During the period Gleeson Strategic Land sold three sites, with a combined acreage of 13 acres.

 

Contracts were exchanged for the sale of the first phase of a 77 acre site in Thanet, in which the Group has 50% interest. The works to install the infrastructure for the whole of the site have now commenced.

 

During the period, planning permission was achieved on a 133 unit site at Grove, Oxfordshire and an 18 unit site at Hunston, West Sussex. Both sites are being marketed for sale in 2013.

 

The strategic land portfolio continues to be replenished. During the period, agreements were entered into regarding six new sites, comprising 126 acres.

 

 

 

The Group's cash balances at 31 December 2012 stood at £10.4m.

Jolyon Harrison, Chief Executive, commented:

 

"The performance in the first half of the financial year of both Gleeson Homes and Gleeson Strategic Land is encouraging, with profits expected to be significantly ahead of last year. The housing market remains challenging. The Group, however, remains on track to deliver a strong and sustained improvement in its performance."

 

 

 

Enquiries:

 

M J Gleeson Group plc

Jolyon Harrison Chief Executive Officer 0114 261 2900

Alan Martin Chief Financial Officer 01252 360 300

 

 

Notes to Editors

 

MJ Gleeson Group plc operates in the house building sector through the following business units; Gleeson Homes, which focuses on estate regeneration and housing development on brownfield land in the North of England; and Gleeson Strategic Land, which purchases options over land in the South of England with the objective of enhancing the value of the site concerned by securing residential planning permission.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBRGDBSDBBGXG
Date   Source Headline
12th Feb 20254:14 pmRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSResults for the half year ended 31 December 2024
7th Feb 202511:51 amRNSDirector/PDMR Shareholding
14th Jan 20257:00 amRNSTrading Update & Notice of Results
7th Jan 20254:28 pmRNSDirector/PDMR Shareholding
9th Dec 20244:59 pmRNSDirector/PDMR Shareholding
3rd Dec 20243:50 pmRNSDirector/PDMR Shareholding
26th Nov 20243:34 pmRNSDirector/PDMR Shareholding
15th Nov 20242:08 pmRNSResult of AGM
15th Nov 20247:00 amRNSAGM Trading Update
7th Nov 20242:44 pmRNSDirector/PDMR Shareholding
30th Oct 202410:42 amRNSDirector/PDMR Shareholding
21st Oct 20247:00 amRNSNotice of AGM
18th Oct 20244:24 pmRNSDirector/PDMR Shareholding
18th Oct 20244:19 pmRNSDirector/PDMR Shareholding
9th Oct 20244:27 pmRNSDirector/PDMR Shareholding
4th Oct 202410:18 amRNSDirector/PDMR Shareholding
30th Sep 20247:00 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSAudited results for the year ended 30 June 2024
9th Sep 202410:18 amRNSDirector/PDMR Shareholding
30th Aug 20247:00 amRNSTotal Voting Rights
7th Aug 20249:41 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSTotal Voting Rights
23rd Jul 20242:36 pmRNSDirector/PDMR Shareholding
23rd Jul 20241:53 pmRNSStandard form for notification of major holdings
11th Jul 20247:00 amRNSFY2024 Trading Update
8th Jul 20241:34 pmRNSDirector/PDMR Shareholding
8th Jul 20247:00 amRNSNotice of Trading Update
28th Jun 20247:00 amRNSTotal Voting Rights
6th Jun 20242:46 pmRNSDirector/PDMR Shareholding
31st May 20247:00 amRNSTotal Voting Rights
15th May 20247:00 amRNSAppointment of Joint Corporate Broker
9th May 20249:41 amRNSDirector/PDMR Shareholding
30th Apr 20247:00 amRNSTotal Voting Rights
8th Apr 20243:41 pmRNSDirector/PDMR Shareholding
3rd Apr 20244:28 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:28 pmRNSDirector/PDMR Shareholding
28th Mar 20247:00 amRNSTotal Voting Rights
22nd Mar 20249:07 amRNSDirector/PDMR Shareholding
20th Mar 20241:45 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSTotal Voting Rights
26th Feb 20241:04 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSResults for the half year ended 31 December 2023
7th Feb 202411:34 amRNSDirector/PDMR Shareholding
31st Jan 20247:00 amRNSTotal Voting Rights
9th Jan 202410:50 amRNSDirector/PDMR Shareholding
9th Jan 20247:00 amRNSTrading Update & Notice of Results
29th Dec 20237:00 amRNSTotal Voting Rights
15th Dec 20232:49 pmRNSRe Directorate External Appointments
6th Dec 20234:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.